Markets | |
Share of JD.com (NASDAQ:JD) surged on March 2 after the company posted an increase in earnings and revenue. The company also posted an increase in annual active customer accounts of over 20% for the quarter. The stock was up over 9% in mid-day trading. This effectively made up for the stock’... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Markets | |
There’s no doubt that apps have certainly streamlined life and made it possible for consumers to do a number of incredible things right from their phone—and one of those things is investing in the stock market at a negligible cost.
7 Best Investment Apps
Robinhood
Acorns
Round
S... Read the Full Story |
|
Markets | | A Lot Deeper, But Don’t Worry About It
The coronavirus sparked a massive sell-off in the broad equities market. The coronavirus is the catalyst that set the sell-off in motion but it is not the underlying cause, the broad equities market has been ripe for correction for well over a year. The ... Read the Full Story |
|
From Our Partners | | Hedge funds are rotating out of AI hype and into the hardware layer powering it. New research identifies three profitable U.S. infrastructure companies leading this shift.
One just posted 76% year-over-year data-center growth. Another holds a $12 billion backlog from global hyperscalers. A third is generating 59%+ gross margins on next-gen chips. | | Access the full analysis, price setups, and catalysts now |
|
Markets | |
There's a dichotomy between mall-focused retail and stand-alone store retail that seems to be growing with each new earnings report that emerges. While stores like Foot Locker and American Eagle falter, and perennial anchor stores from Sears (OTCMKTS: SHLDQ) to Macy's (NYSE: M) to JCPenney (NYSE: ... Read the Full Story |
|
Markets | | Despite the coronavirus's best efforts to take down the stock market with no prisoners in recent days, TJX Companies (NYSE: TJX) had just the remedy shareholders were looking for. The off-price department store released red hot Q4 earnings on Wednesday that crushed analyst expectations and sent the... Read the Full Story |
|
From Our Partners | | Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldrush, and Cortez Hills, deposits that could hold up to 60 million ounces of gold.
One overlooked explorer controls 142 claims bordering Fourmile and sitting less than a mile from Goldrush. New geological modeling aims to reveal what's beneath this largely untested ground, while a planned 5% royalty spin-off could give shareholders a separate stake in the project. | | Read the full report before the next catalyst hits |
|
Markets | |
Marriott (NASDAQ:MAR) will report earnings on February 25 after the market closes. The results will account for the quarter prior to the COVID-19 (i.e. coronavirus) outbreak. Therefore, I expect the company will post earnings and revenue numbers that will meet or exceed analysts’ expectation... Read the Full Story |
|
Markets | |
When a drug gets FDA approval for an expanded label, the company stock typically enjoys a “halo effect”. This is a period where the stock runs up on positive publicity.
Investors may have expected Amarin (NASDAQ:AMRN) stock to get the benefit of a halo effect after its drug, Vascepa, ... Read the Full Story |
|
Markets | |
There’s nothing like entering a trade with confidence and watching your account value go up in real-time. Unfortunately, for many traders, looking at their live P&L, also known as “Profit and Loss”, can be an issue that derails their trading progress. This is particularly tru... Read the Full Story |
|
Markets | | Pizza delivery restaurant chain Papa John’s International (NASDAQ: PZZA) shares have been recovering since bottoming out in the 38s during the racism scandal with its founder John Schnatter in 2018. NBA Hall of Famer Shaquille O’Neal was brought onboard as the company’s brand ambas... Read the Full Story |
|
Markets | |
Spring is right around the corner. And for many homeowners in parts of the nation that have grown weary of cold, gray winter days, spring turns their thoughts to outdoor projects. And this means that spring is a time when lawns aren’t the only thing seeing green.
We are now approaching the ... Read the Full Story |
|
The Early Bird Stock Of The Day West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. | | View Today's Stock Pick |
|
